Statins, ACE inhibitors lower risk of death from COVID-19 | EHR data detects high-risk patients | VR for cardiologists

The study, published in JAMA Network Open, included data from more than 64,000 COVID-19 patients.

When the patient had a history of stroke or heart failure, the researchers noted, their prediction model was less accurate. 

According to Abbott, similar programs have improved cath lab learning engagement by 45%.

Cardiologist Peter A. McCullough, MD, appeared on Fox News to discuss the medical community’s “therapeutic nihilism” when it comes to potential COVID-19 treatments such as hydroxychloroquine.

The risk of major bleeding or life-threatening bleeding events was higher when clopidogrel was included in the patient's treatment strategy. 

In fact, the authors noted, CCTA outperformed SPECT in some key areas. 

The authors emphasized the importance of investing in "substance use treatment, harm reduction, and structural drivers of overdose" as the pandemic continues. 

This week NPR has posted three interactive infographics that health execs may find especially valuable as COVID-19 surges in spots across the U.S. and around the world.

The move would also provide flexibilities to disclose information in emergency situations, such as the COVID-19 pandemic and opioid crisis.